Oppenheimer & Co. Inc. Takes Position in Repligen Co. (NASDAQ:RGEN)
Oppenheimer & Co. Inc. purchased a new stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 1,500 shares of the biotechnology company’s stock, valued at approximately $216,000. A number of other large investors have also […]
Oppenheimer & Co. Inc. purchased a new stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 1,500 shares of the biotechnology company’s stock, valued at approximately $216,000. A number of other large investors have also […]
